FdaApplication
BLA 761097
Identifiers
- fda_app_no: BLA761097
Properties
| Property | Value |
|---|---|
| applicant_name | Regeneron Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2018-09-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LIBTAYO | CEMIPLIMAB-RWLC | 350MG/7ML (50MG/ML) | Injection |
1 product